+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05911620

Assessing Liver Fibrosis Severity Using Magnetic Resonance Elastography in Adults with Cushings Syndrome or Metabolic Syndrome

Led by Central Hospital, Nancy, France · Updated on 2023-10-25

21

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are investigating the possible presence and severity of liver fibrosis in adults diagnosed with endogenous Cushings syndrome, especially in its more severe forms. This exploratory study, known as HEPACORT, uses Magnetic Resonance Elastography MRE to assess liver stiffness and fibrosis in patients with confirmed or suspected Cushings syndrome, as well as those with metabolic syndrome. The goal is to better understand liver involvement in these conditions.

CONDITIONS

Brief Title

Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism

Research Team

N

Nicolas SCHEYER, MD

G

Guillaume DROUOT, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here